HER2 Vaccine for Locally Advanced Breast Cancer

The goal of this study is to test an investigational vaccine to activate the immune system to fight breast cancer.

Trial Details

NCT ID
NCT06949410
Phase
PHASE1
Sponsor
Pravin T.P Kaumaya
Status
RECRUITING
Cancer Type
HER2 Positive Breast Cancer
Interventions
  • HER2 Vaccine
Locations (sample)
  • Indianapolis, Indiana, United States|39.76838,-86.15804

Key Eligibility Criteria

  • ≥ 18 years old at the time of informed consent
  • Ability to provide written informed consent and HIPAA authorization CTO-IUSCC-0864
  • Histologically confirmed HER2 positive breast cancer
  • Any Estrogen Receptor/Progesterone Receptor status is allowed.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find HER2 Positive Breast Cancer Trials on Trialify →